Nuvalent, Inc.
NUVLDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001861560
Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Nuvalent, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 217
- +26 vs. Q3 2024
- Shares held
- 70.6M
- +586.6K (+0.8%) vs. Q3 2024
- Total value
- $5.53B
- −$1.64B (−22.8%) vs. Q3 2024
- New holders
- 50
- 95 more added
- Sold out
- 24
- 51 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NUVL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 292 | $9.29B |
| Q1 2026 | 265 | $8.30B |
| Q4 2025 | 237 | $8.04B |
| Q3 2025 | 196 | $6.26B |
| Q2 2025 | 209 | $5.49B |
| Q1 2025 | 205 | $5.11B |
| Q4 2024 | 217 | $5.53B |
| Q3 2024 | 193 | $7.17B |
| Q2 2024 | 172 | $4.98B |
| Q1 2024 | 180 | $4.78B |
| Q4 2023 | 155 | $4.68B |
| Q3 2023 | 116 | $2.57B |
| Q2 2023 | 111 | $2.33B |
| Q1 2023 | 89 | $1.41B |
| Q4 2022 | 96 | $1.58B |
| Q3 2022 | 60 | $879.5M |
| Q2 2022 | 55 | $622.5M |
| Q1 2022 | 55 | $629.0M |
| Q4 2021 | 49 | $813.1M |
| Q3 2021 | 47 | $941.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Nuvalent, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Driehaus Capital Management LLC | 793,416 | $62.1M | 0.51% | −70,541−8.2% | Reduced |
| Geode Capital Management, LLC | 871,488 | $68.2M | 0.01% | +15,878+1.9% | Added |
| Polar Capital Holdings Plc | 946,723 | $74.1M | 0.41% | +584,223+161.2% | Added |
| Boxer Capital Management, LLC | 1,120,192 | $87.7M | 7.47% | +1,120,192 | New |
| Woodline Partners LP | 1,204,927 | $94.3M | 0.64% | +11,248+0.9% | Added |
| Wellington Management Group LLP | 1,284,575 | $100.6M | 0.02% | +272,738+27.0% | Added |
| Price T Rowe Associates Inc | 1,297,910 | $101.6M | 0.01% | +215,633+19.9% | Added |
| Fairmount Funds Management LLC | 1,317,664 | $103.1M | 10.25% | −369,400−21.9% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 1,447,267 | $113.3M | 13.33% | −1,250,000−46.3% | Reduced |
| State Street Corp | 1,489,680 | $116.6M | 0.00% | +246,581+19.8% | Added |
| Commodore Capital LP | 1,621,600 | $126.9M | 9.30% | +681,600+72.5% | Added |
| Perceptive Advisors LLC | 2,619,977 | $205.1M | 5.71% | −359,258−12.1% | Reduced |
| BlackRock, Inc. | 3,851,577 | $301.5M | 0.01% | +226,596+6.3% | Added |
| Vanguard Group Inc | 4,499,864 | $352.2M | 0.01% | +366,239+8.9% | Added |
| Paradigm Biocapital Advisors LP | 5,363,379 | $419.8M | 14.61% | +363,379+7.3% | Added |
| FMR LLC | 9,654,326 | $755.7M | 0.05% | −260.0% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 17,991,024 | $1.41B | 26.79% | −2,000,000−10.0% | Reduced |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −1,120,192−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −176,281−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −40,130−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −38,310−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| BCJ Capital Management, LLC | 0 | $0 | 0.00% | −24,195−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −12,264−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −11,640−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −10,442−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Advantage Alpha Capital Partners LP | 0 | $0 | 0.00% | −4,851−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −4,533−100.0% | Sold out |
| Valence8 US LP | 0 | $0 | 0.00% | −4,115−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,255−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −3,202−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −2,556−100.0% | Sold out |
| Torno Capital, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Xponance, Inc. | 0 | $0 | 0.00% | −2,243−100.0% | Sold out |
| Portland Investment Counsel Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −1,564−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| Eagle Asset Management Inc | – | – | – | – | Not filed |
| Raymond James & Associates | – | – | – | – | Not filed |